MMedication Read More Telehealth sees rising off-label use of GLP-1s for substance abuseOctober 22, 2026 Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
MMedication Read More NVO’s Ozempic Outshines LLY’s Mounjaro in Lowering Cardiovascular RiskOctober 1, 2026 Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in adults…
HHealthcare Read More The reason your healthcare premiums are skyrocketing? AI.September 29, 2026 Rising healthcare costs are hammering Americans, and now artificial intelligence is raising the price tag even more. The…
HHealthcare Read More Doctors Share The Habits They Changed After Seeing Patients SufferSeptember 15, 2026 People who work in medical professions, like doctors, nurses, and EMTs, often see firsthand what can happen to…
MMedication Read More The new GLP-1 weight-loss pill vs. the shot: a doctor’s answer on oral WegovySeptember 14, 2026 FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025, and it…
MMedication Read More Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Trial Conducted by Akeso in ChinaAugust 26, 2026 HARMONi-GI1 Conducted in China by Akeso Is First Known Phase III Study in Advanced BTC to Demonstrate OS…
HHealthcare Read More Influenza A surge: Flu patients face corridor beds and 10-hour waitsAugust 21, 2026 “They are so incredibly under-resourced,” she said. In the past fortnight, a surge of influenza A cases has…
MMedication Read More EyePoint’s Duravyu falls short to Eylea in Phase III trialAugust 19, 2026 EyePoint’s stock dropped 67% after its potential Eylea (aflibercept) competitor Duravyu fell short in a Phase III trial…
MMedication Read More The new GLP-1 weight-loss pill vs. the shot: A doctor’s honest answer on oral WegovyAugust 17, 2026 FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025, and it…
HHealthcare Read More JB hospital sees surge in Singapore patients using MediSave for treatmentAugust 13, 2026 LOOK BEYOND STICKER PRICE, SAYS EXPERT Lower treatment costs are a significant draw for patients considering healthcare procedures…
HHealthcare Read More US Nurse Fired Over Video Suggesting She Avoids Patients Watching Fox NewsJuly 9, 2026 The University of Texas Medical Branch (UTMB) has fired a nurse after investigating a viral social media video…
MMedication Read More European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review ProcessJuly 8, 2026 Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…